echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Judging the development trend of China's medical industry and marketization of high-end demand

    Judging the development trend of China's medical industry and marketization of high-end demand

    • Last Update: 2014-09-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: Wealth Management September 26, 2014 with the continuous improvement of people's living standards and the acceleration of population aging, the demand for medical services is steadily increasing, the medical service industry is about to enter a rapid growth period, and commercial medical institutions have better investment value The value return of medical service industry is the future trend At present, China's medical service is an undervalued special commodity, which is not only a high-quality commodity in short supply, but also a public welfare product to save lives and injuries For a long time, our country has been emphasizing the public welfare of medical service, but ignoring its commodity attribute, which makes the value of high-quality medical service seriously underestimated The underestimation of the value of medical service resources is not only reflected in the low skill pricing, but also in the low proportion of salary expenditure in the domestic medical system At present, drugs account for about half of the hospital income structure in China, while the proportion of medical services is obviously low With the deepening of the new medical reform, the status quo of "focusing on drugs and ignoring services" will be gradually corrected, and the medical service will experience the value return under the marketization, which will also promote the prosperity of the medical service industry The basic demand is public welfare and the high-end demand is market-oriented With the acceleration of population aging, the investment of government health funds will continue to increase, but relative to the huge demand is always limited Government resources should be invested in the grass-roots medical system which can better reflect the public welfare, so as to maximize the cost-effectiveness of investment At the same time, it can improve the operation efficiency of the medical system to stay at the level of grass-roots hospitals However, the demand for high-end medical care should be market-oriented and purchased by wealthy people with the ability to pay The ultimate goal of marketization is to make resource allocation more reasonable From the practice of global medical system reform, the realization of universal medical security can be achieved by different ways No matter what kind of medical system reform, the goal is to achieve a comprehensive coverage of grass-roots security, that is, public welfare of basic needs High end demand will be priced through market supply and demand Therefore, in the future, the development direction of medical services will present the trend of "public welfare of basic needs, marketization of high-end needs" High end medical treatment will become an important growth point of medical market In terms of the growth of the number of hospitals in recent years, the growth rate of specialized hospitals representing high-end demand, such as beauty, stomatology and maternity, is much higher than the overall growth rate Rich people pay more attention to service quality than general medical service consumers They are not sensitive to price, or enjoy high-end medical insurance, and can bear high medical expenses This will be the area where future investment opportunities are concentrated Accordingly, high-end medical insurance will become an important growth point of commercial health insurance market In 2012, premium of high-end medical insurance of national insurance companies was about 900 million yuan It is predicted that in the next five years, about 30-40 million people in China will need high-end medical services every year, and the market capacity of high-end medical insurance will reach at least 20 billion yuan, which will be gradually pushed from the first tier central cities such as Shanghai and Beijing to the second tier cities in the central and western regions such as Suzhou, Nanjing, Chengdu and Wuhan.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.